Skip to content
npo-uniken
  • Advertising & Marketing
  • Business export inport
  • finance & accounting
  • Finance & Oportunity
  • Business & Finance
  • News Business
  • About Us
    • Advertise Here
    • Contact Us
    • Privacy Policy
    • Sitemap

Tag: Reports

  • Home
  • Reports
Posted on August 21, 2021 by: Talia Koe

NexImmune Reports Second Quarter 2021 Financial Results and Provides Business Updates

Announcing first solid tumor indication in HPV associated-malignancies – NEXI-003 Advancing two lead product candidates in Phase 1/2 clinical trials Additional clinical and preclinical data …

Continue Reading
Posted on August 16, 2021 by: Talia Koe

Cyteir Therapeutics Reports Second Quarter 2021 Financial Results and Provides Business Highlights

– IPO raised an aggregate of approximately $149.1 million in gross proceeds – Strong cash position of $198.6 million to be used to deliver expected …

Continue Reading
Posted on August 15, 2021 by: Talia Koe

Epizyme Reports Second Quarter 2021 Financial Results and Provides Business Update

Total Revenue of $13.0 Million in 2Q 2021; TAZVERIK® Net Product Revenues of $8.0 Million Revised Commercial Strategy and Operating Plan to Accelerate Adoption of …

Continue Reading
Posted on August 5, 2021 by: Talia Koe

Pharvaris Reports Second Quarter 2021 Financial Results and Provides Business Highlights

RAPIDe-1, Phase 2 on-demand study of PHVS416 for the treatment of HAE attacks expanding to US, expected to report data in 2022 CHAPTER-1, Phase 2 …

Continue Reading
Posted on August 4, 2021 by: Talia Koe

Retail Opportunity Investments Corp. Reports Second Quarter 2021 Results

SAN DIEGO, July 28, 2021 (GLOBE NEWSWIRE) — Retail Opportunity Investments Corp. (NASDAQ:ROIC) announced today financial and operating results for the three and six months …

Continue Reading
Posted on May 26, 2021 by: Talia Koe

Stealth BioTherapeutics Reports First Quarter 2021 Financial Results And Recent Business Highlights

Phase 3 randomized withdrawal trial for cardiomyopathy in Barth planned ReCLAIM Phase 1 data presented at ARVO 2021 supports ReCLAIM-2 Phase 2 geographic atrophy trial …

Continue Reading
Posted on May 23, 2021 by: Talia Koe

SinglePoint Reports First Quarter 2021 Financial Results and Provides Business Update

– Continued execution on strategy to build the most comprehensive national solar network and portfolio of renewable energy solutions to meet rapidly growing demand – …

Continue Reading
Posted on May 22, 2021 by: Talia Koe

Mydecine Reports First Quarter 2021 Financial Results and Provides Business Update

Strategic Partnerships Expand Drug Development Capabilities to More Efficiently and Rapidly Lead the Next Generation of Psychedelic-Assisted Therapeutics DENVER, May 18, 2021 (GLOBE NEWSWIRE) — …

Continue Reading
Posted on May 15, 2021 by: Talia Koe

Aldeyra Therapeutics Reports First-Quarter 2021 Financial Results and Recent Business Highlights

Recently Announced Phase 3 INVIGORATE Clinical Trial Results Indicated Statistically Significant Activity of Reproxalap in Ocular Itching and Redness Associated with Allergic Conjunctivitis Top-Line Results …

Continue Reading
Posted on May 15, 2021 by: Talia Koe

Dun & Bradstreet Reports First Quarter 2021 Financial Results

Dun & Bradstreet Holdings, Inc. (NYSE: DNB), a leading global provider of business decisioning data and analytics, today announced unaudited financial results for the first …

Continue Reading
Posted on May 11, 2021 by: Talia Koe

Aprea Therapeutics Reports First Quarter 2021 Financial Results and Provides Update on Business Operations

BOSTON, May 06, 2021 (GLOBE NEWSWIRE) — Aprea Therapeutics, Inc. (Nasdaq: APRE), a biopharmaceutical company focused on developing and commercializing novel cancer therapeutics that reactivate …

Continue Reading
Posted on May 8, 2021 by: Talia Koe

Mirum Pharmaceuticals Reports First Quarter 2021 Financial Results and Provides Business Update

– NDA for maralixibat in Alagille syndrome (ALGS) granted priority review by U.S. FDA; PDUFA date is September 29, 2021– Received additional $65.0 million in …

Continue Reading
Posted on May 2, 2021 by: Talia Koe

AnalytixInsight Reports 2020 Financial Results and Provides Business Update

TORONTO, April 26, 2021 (GLOBE NEWSWIRE) — Artificial Intelligence company, AnalytixInsight Inc. (“AnalytixInsight”, or the “Company”) (TSX-V: ALY; OTCQB: ATIXF), reports its financial results for …

Continue Reading
Posted on April 29, 2021 by: Talia Koe

Lufax Reports First Quarter 2021 Unaudited Financial Results | Business & Finance

SHANGHAI–(BUSINESS WIRE)–Apr 26, 2021– Lufax Holding Ltd (“Lufax” or the “Company”) (NYSE: LU), a leading technology-empowered personal financial services platform in China, today announced its …

Continue Reading
Posted on April 3, 2021 by: Talia Koe

Phio Pharmaceuticals Reports 2020 Year End Financial Results and Provides Business Update

MARLBOROUGH, Mass., March 25, 2021 /PRNewswire/ — Phio Pharmaceuticals Corp. (Nasdaq: PHIO), a biotechnology company developing the next generation of immuno-oncology therapeutics based on its …

Continue Reading
Posted on March 29, 2021 by: Talia Koe

Panbela Provides Business Update and Reports Q4 and FY 2020 Financial Results

MINNEAPOLIS, March 26, 2021 (GLOBE NEWSWIRE) — Panbela Therapeutics, Inc. (Nasdaq: PBLA), is re-issuing this press release solely to correct an inadvertent decimal error in …

Continue Reading
Posted on March 27, 2021 by: Talia Koe

OSE Immunotherapeutics Reports 2020 Financial Results and Provides Business Update

Major expansion of clinical portfolio including initiation of clinical trials with Tedopi® in ovarian cancer, OSE-127/S95011 in ulcerative colitis, FR104 in renal transplant and an …

Continue Reading
Posted on March 22, 2021 by: Talia Koe

Cocrystal Pharma Reports 2020 Financial Results, Provides Business Update Including Antiviral Program Milestones

Outlines 2021 product pipeline milestones for COVID-19, influenza A and norovirus antiviral programs Ends 2020 with cash exceeding $33 million and a clean capital structure …

Continue Reading
Posted on March 18, 2021 by: Talia Koe

Diffusion Pharmaceuticals Reports 2020 Financial Results and Provides Business Update

CHARLOTTESVILLE, Va., March 17, 2021 (GLOBE NEWSWIRE) — Diffusion Pharmaceuticals Inc. (NASDAQ: DFFN) (“Diffusion” or the “Company”), an innovative biopharmaceutical company developing novel therapies that …

Continue Reading
Posted on March 4, 2021 by: Talia Koe

Vaxart Provides Business Update and Reports Fourth Quarter and Full Year 2020 Financial Results

VXA-CoV2-1 oral COVID-19 vaccine candidate targeting both the S and N proteins is planned to advance to Phase 2 testing during Q2 2021 Cash and …

Continue Reading

Posts navigation

Previous

Recent Posts

  • Thirteen Finest Electronic Outlets In Nairobi
  • Entravision Announces Promotion of Karina Cerda to Executive Vice President of Global Marketing | National Business
  • Here’s why Intel’s bad quarter is good news for rival chipmaker AMD
  • U.S. exports, business spending may salvage second-quarter GDP | U.S. & World
  • Entravision Ups Cerda To Global Marketing EVP

Archives

  • August 2022
  • July 2022
  • June 2022
  • May 2022
  • April 2022
  • March 2022
  • December 2021
  • October 2021
  • September 2021
  • August 2021
  • July 2021
  • June 2021
  • May 2021
  • April 2021
  • March 2021
  • February 2021
  • January 2021
  • December 2020
  • November 2020
  • November 2018
  • October 2018
  • December 2016

Categories

  • Advertising & Marketing
  • Business & Finance
  • Business export inport
  • finance & accounting
  • Finance & Oportunity
  • General
  • News Business

bayar.ooo

Visit Now

Another example

BL

TL

Intellifluence Trusted Blogger
npo-uniken.org All Rights Reserved | Magpaper by Theme Palace